Some Pharma Makers Leery of Further Cut into Off-Patent Brands in Japan

As Japan started a new fiscal year on April 1, an “off-year” price revision was implemented to update the NHI prices of a vast number of medicines on the reimbursement list. A Jiho poll drew many complaints over the revision...read more